General haemostatic agents - Fact or fiction?

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue SUPPL. 1, 2002, Pages 33-36

  Hedner, Ulla ^a,b  

^a NOVO NORDISK A S   (Denmark)

^b Novo Nordisk Scandinavia   (Sweden)

Author keywords

Haemostasis failure; rFVIIa; Thrombin

Indexed keywords

ADRENALIN; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRIN; FIBRINOGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; BLOOD CLOTTING FACTOR 7; HEMOSTATIC AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

BINDING AFFINITY; BLEEDING; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEMOPHILIA; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBIN TIME; ARTICLE; BIOSYNTHESIS; HEMOPHILIA A; METABOLISM; PHYSIOLOGY;

FACTOR VII; FIBRIN; HEMOPHILIA A; HEMOSTASIS; HEMOSTATICS; HUMANS; RECOMBINANT PROTEINS; THROMBIN;

EID: 0038082591     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057299     Document Type: Review

References (19)

1. Berruyer M, Amiral J, Ffrench P, Belleville J, Bastien O, Clerc J, Kassir A, Estanove S, Dechavanne M: Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg 1993;105:892-897.
2. Chouhan VD, De La C, Nagaswami C, Weisel JW, Kajani M, Rao AK: Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: Effects on blood coagulation, protein C activation and platelet function. Thromb Haemost 1997;77:343-349.
3. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U: Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992;80:25-28.
4. Rapaport SI, Rao LV: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992;12:1111-1121.
5. Rapaport SI, Rao LV: The tissue factor pathway: How it has become a 'prima ballerina'. Thromb Haemost 1995;74:7-17.
6. Blomback B, Carlsson K, Fatah K, Hessel B, Procyk R: Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation. Thromb Res 1994;75:521-538.
7. Hoffman M, Monroe DM, Oliver JA, Roberts HR: Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995;86:1794-1801.
8. Monroe DM, Hoffman M, Oliver JA, Roberts HR: Platelet activity of high-dose factor VIIa is independent of tissue factor. Brit J Haematol 1997;99:542-547.
9. Hedner U: NovoSeven as a Universal haemostatic agent. Blood Coagulation Fibrinolysis 2000;11(suppl 1):107-111.
10. Kjalke M, Ezban M, Hedner U: Increased initial thrombin generation may explain the efficacy of high-dose factor VIIa in thrombocytopenia. Blood 1999;94:451a.
11. He S, Blomback M, Hedner U: Effect of rFVIIa on the permeability of fibrin gel. Thromb Haemost 2001;CD3315 (abstract).
12. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA: Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998;80:773-778.
13. Keularts IM, Beguin S, de Zwaan C, Hemker HC: Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients. Thromb Haemost 1998;80:370-371.
14. Kjalke M, Ezban M, Monroe DM, Hoffman M, Roberts HR, Hedner U: High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. Br J Haematol 2001;114:114-120.
15. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U: Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996;26(suppl 1):159-164.
16. Poon MC, Demers C, Jobin F, Wu JW: Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999;94:3951-3953.
17. McDonagh J, Fukue H: Determinants of substrate specificity for factor XIII. Semin Thromb Hemost 1996;22:369-376.
18. Kenet G, Walden R, Eldad A, Martinowitz U: Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999;354:1879.
19. Martinowitz U, Holcomb JB, Pusateri AE, Stein M, Onaca N, Freidman M, Macaitis JM, Castel D, Hedner U, Hess JR: Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 2001;50:721-729.